308 related articles for article (PubMed ID: 30905487)
21. Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.
Alotaibi F
J Infect Public Health; 2019; 12(4):465-471. PubMed ID: 31060974
[TBL] [Abstract][Full Text] [Related]
22. The rapid spread of carbapenem-resistant Enterobacteriaceae.
Potter RF; D'Souza AW; Dantas G
Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
[TBL] [Abstract][Full Text] [Related]
23. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
Martirosov DM; Lodise TP
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
[TBL] [Abstract][Full Text] [Related]
24. Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit.
Abdallah M; Badawi M; Alzaagi I; Issa KN; Rasheed A; Alharthy A
J Chemother; 2019 Sep; 31(5):261-266. PubMed ID: 30983552
[TBL] [Abstract][Full Text] [Related]
25. Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.
Kuntaman K; Shigemura K; Osawa K; Kitagawa K; Sato K; Yamada N; Nishimoto K; Yamamichi F; Rahardjo D; Hadi U; Mertaniasih NM; Kinoshita S; Fujisawa M; Shirakawa T
Int J Urol; 2018 Nov; 25(11):966-972. PubMed ID: 30253445
[TBL] [Abstract][Full Text] [Related]
26. Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis.
Li YY; Wang J; Wang R; Cai Y
BMC Infect Dis; 2020 Jun; 20(1):408. PubMed ID: 32527246
[TBL] [Abstract][Full Text] [Related]
27. Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae.
Carrara E; Bragantini D; Tacconelli E
Curr Opin Infect Dis; 2018 Dec; 31(6):594-599. PubMed ID: 30299357
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
Kaur A; Gandra S; Gupta P; Mehta Y; Laxminarayan R; Sengupta S
Am J Infect Control; 2017 Nov; 45(11):1289-1291. PubMed ID: 28807425
[TBL] [Abstract][Full Text] [Related]
29. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.
El-Herte RI; Kanj SS; Matar GM; Araj GF
J Infect Public Health; 2012 Jun; 5(3):233-43. PubMed ID: 22632597
[TBL] [Abstract][Full Text] [Related]
30. Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.
Thaden JT; Pogue JM; Kaye KS
Virulence; 2017 May; 8(4):403-416. PubMed ID: 27384881
[TBL] [Abstract][Full Text] [Related]
31. Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections.
King M; Heil E; Kuriakose S; Bias T; Huang V; El-Beyrouty C; McCoy D; Hiles J; Richards L; Gardner J; Harrington N; Biason K; Gallagher JC
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483952
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of carbapenemase producing Enterobacteriaceae peritonitis: 'Old therapy for a new bug'.
O'Riordan J; Bhally HS; Salmon AH; de Zoysa JR
Perit Dial Int; 2020 Jan; 40(1):100-102. PubMed ID: 32063148
[TBL] [Abstract][Full Text] [Related]
33. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
[TBL] [Abstract][Full Text] [Related]
34. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.
van Duin D; Lok JJ; Earley M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Doi Y; Kaye KS; Fowler VG; Paterson DL; Bonomo RA; Evans S;
Clin Infect Dis; 2018 Jan; 66(2):163-171. PubMed ID: 29020404
[TBL] [Abstract][Full Text] [Related]
35. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
36. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
White BP; Patel S; Tsui J; Chastain DB
Infect Dis (Lond); 2019 Mar; 51(3):161-167. PubMed ID: 30663923
[TBL] [Abstract][Full Text] [Related]
37. Carbapenem-resistant Enterobacteriaceae in Pediatric Bloodstream Infections in Rural Southern India.
Sekar R; Mythreyee M; Srivani S; Sivakumaran D; Lallitha S; Saranya S
Indian Pediatr; 2017 Dec; 54(12):1021-1024. PubMed ID: 28849764
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
Nabarro LE; Veeraraghavan B
Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2307-11. PubMed ID: 26363636
[TBL] [Abstract][Full Text] [Related]
39. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Stewardson AJ; Marimuthu K; Sengupta S; Allignol A; El-Bouseary M; Carvalho MJ; Hassan B; Delgado-Ramirez MA; Arora A; Bagga R; Owusu-Ofori AK; Ovosi JO; Aliyu S; Saad H; Kanj SS; Khanal B; Bhattarai B; Saha SK; Uddin J; Barman P; Sharma L; El-Banna T; Zahra R; Saleemi MA; Kaur A; Iregbu K; Uwaezuoke NS; Abi Hanna P; Feghali R; Correa AL; Munera MI; Le TAT; Tran TTN; Phukan C; Phukan C; Valderrama-Beltrán SL; Alvarez-Moreno C; Walsh TR; Harbarth S
Lancet Infect Dis; 2019 Jun; 19(6):601-610. PubMed ID: 31047852
[TBL] [Abstract][Full Text] [Related]
40. Revival of old antibiotics: needs, the state of evidence and expectations.
Zayyad H; Eliakim-Raz N; Leibovici L; Paul M
Int J Antimicrob Agents; 2017 May; 49(5):536-541. PubMed ID: 28162982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
